Type 2 Diabetes Mellitus Therapeutic Market Analysis 2026

Global Type 2 Diabetes Mellitus Therapeutic Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Type 2 Diabetes Mellitus Therapeutic Market Report Description

We have various report editions of Type 2 Diabetes Mellitus Therapeutic Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Type 2 Diabetes Mellitus Therapeutic Market Insights Video

Competitive Landscape of the Type 2 Diabetes Mellitus Therapeutic Market

The Type 2 diabetes mellitus therapeutic market is highly competitive, with key players dominating a diverse portfolio of medications such as GLP-1 receptor agonists, SGLT2 inhibitors, and insulin therapies. Innovation and partnerships drive competition, with firms focusing on developing next-generation drugs, improving patient outcomes, and expanding market reach. Additionally, market players are investing in digital health solutions and personalized medicine to enhance diabetes management.

In April 2024, Sanofi launched its diabetes medication Soliqua in India following the receipt of marketing authorization from the Central Drugs Standard Control Organization (CDSCO). This introduction marks a significant expansion of Sanofi's diabetes care offerings in the Indian market. (Source: https://www.sanofi.in/dam/jcr:00aa3c72-86bf-4973-81f6-862238b832d4/Sanofi-India-receives-marketing-approval-for-its-diabetes-drug-Soliqua-in-India.pdf) In May 2022, the US Food and Drug Administration (FDA) granted approval for Mounjaro (tirzepatide), an injection developed by Eli Lilly to enhance blood sugar control in adults with Type 2 diabetes (T2D). (Source: https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-mounjarotm-tirzepatide-injection-first-and#:~:text=INDIANAPOLIS%20%2C%20May%2013%2C%202022%20%2F,as%20an%20adjunct%20to%20diet)

Top Companies Market Share in Type 2 Diabetes Mellitus Therapeutic Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Type 2 Diabetes Mellitus Therapeutic Market

Which Region Dominates the Type 2 Diabetes Mellitus Therapeutic Market in 2024?

According to Cognitive Market Research, North America currently dominates the Type 2 Diabetes Mellitus Therapeutics market, and the region is expected to have significant growth during the projected period. This is due to the high prevalence rates of diabetes, advanced healthcare infrastructure, and strong adoption of innovative treatments.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The rising prevalence of Type 2 diabetes, coupled with improved healthcare access and government initiatives, is driving demand for advanced treatments across the region.

The current report Scope analyzes Type 2 Diabetes Mellitus Therapeutic Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Type 2 Diabetes Mellitus Therapeutic Market Analysis

According to Cognitive Market Research, the global Type 2 Diabetes Mellitus Therapeutic market size was estimated at USD 19514.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 7805.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Type 2 Diabetes Mellitus Therapeutic market with a market size of USD 6158.78 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period due to the advancements in diabetes management technologies.
• The Canada Type 2 Diabetes Mellitus Therapeutic market had a market share of USD 936.70 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period due to increased awareness and early diagnosis.
• The Mexico Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 710.33 million in 2024.

Europe Type 2 Diabetes Mellitus Therapeutic Market Analysis

According to Cognitive Market Research, the global Type 2 Diabetes Mellitus Therapeutic market size was estimated at USD 19514.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 5854.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

• The United Kingdom Type 2 Diabetes Mellitus Therapeutic market had a market share of USD 983.53 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period. In the UK, Type 2 Diabetes Mellitus Therapeutic sales witness an upswing due to the advancements in diabetes management and drug development.
• The France Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 538.60 million in 2024.
• According to Cognitive Market Research, the German Type 2 Diabetes Mellitus Therapeutic market size was valued at USD 1159.16 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. In Germany, Type 2 Diabetes Mellitus Therapeutic surged due to the growing government initiatives and healthcare investments.
• The Italy Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 503.47 million in 2024.
• The Russia Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 907.42 million in 2024.
• The Spain Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 6.4% during the forecast period with a market size of USD 480.06 million in 2024
• The Luxembourg Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 181.48 million in 2024.
• The Portugal Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 122.94 million in 2024.
• The Greece Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 70.25 million in 2024.
• The Rest of Europe's Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 907.42 million in 2024.

Asia Pacific Type 2 Diabetes Mellitus Therapeutic Market Analysis

According to Cognitive Market Research, the global Type 2 Diabetes Mellitus Therapeutic market size was estimated at USD 19514.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 4488.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.

• According to Cognitive Market Research, the China Type 2 Diabetes Mellitus Therapeutic market size was valued at USD 2019.75 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period. Type 2 Diabetes Mellitus Therapeutic surged in China due to the increasing healthcare investments and access to treatment.
• The Japan Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 619.39 million in 2024.
• The India Type 2 Diabetes Mellitus Therapeutic market had a market share of USD 538.60 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period due to the growing awareness and adoption of diabetes management solutions.
• The South Korean Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 448.83 million in 2024.
• The Australian Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 233.39 million in 2024.
• The South East Asia Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 309.70 million in 2024.
• The Rest of Asia Pacific Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 10.6% during the forecast period, with a market size of USD 318.67 million in 2024.

South America Type 2 Diabetes Mellitus Therapeutic Market Analysis

According to Cognitive Market Research, the global Type 2 Diabetes Mellitus Therapeutic market size was estimated at USD 19514.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 975.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Type 2 Diabetes Mellitus Therapeutic market size was valued at USD 417.61 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Type 2 Diabetes Mellitus Therapeutics flourished in Brazil due to the increasing prevalence of type 2 diabetes.
• Argentina's Type 2 Diabetes Mellitus Therapeutic market had a market share of USD 163.92 million in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period due to the rising healthcare investments and access.
• Colombia's Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 86.84 million in 2024.
• Peru's Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 80.01 million in 2024.
• Chile's Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 70.25 million in 2024.
• The Rest of Latin America's Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 157.09 million in 2024.

Middle East Type 2 Diabetes Mellitus Therapeutic Market Analysis

According to Cognitive Market Research, the global Type 2 Diabetes Mellitus Therapeutic market size was estimated at USD 19514.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 390.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031..

• The GCC Countries Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 167.04 million in 2024. Type 2 Diabetes Mellitus Therapeutic sales flourish due to the increasing healthcare infrastructure and access.
• The Egypt Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 40.68 million in 2024.
• The South Africa Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 61.67 million in 2024. Type 2 Diabetes Mellitus Therapeutic sales flourished in South Africa due to the growing awareness and adoption of diabetes management programs.
• The Turkey Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 33.56 million in 2024.
• The Nigeria Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 40.98 million in 2024.
• The Rest of the MEA Type 2 Diabetes Mellitus Therapeutic market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 46.05 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.